BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:27 PM
 | 
May 23, 2008
 |  BC Extra  |  Clinical News

GTx's toremifene misses interim efficacy analysis

GTx (NASDAQ:GTXI) was off $1.61 (10%) to $14.63 on Friday after an independent biometrics group reported that 20 mg toremifene did not meet the prespecified statistical significance level at an interim efficacy analysis...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >